HSP90 inhibition drives degradation of FGFR2 fusion proteins: implications for treatment of cholangiocarcinoma
Lamberti, Dante, Cristinziano, Giulia, Porru, Manuela, Leonetti, Carlo, Egan, Jan B., Shi, Chang-Xin, Buglioni, Simonetta, Amoreo, Carla A., Castellani, Loriana, Borad, Mitesh J., Alemà, Stefano, AnasLanguage:
english
Journal:
Hepatology
DOI:
10.1002/hep.30127
Date:
August, 2018
File:
PDF, 819 KB
english, 2018